Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
PI3K-Akt signaling pathway | R-HSA-168638 | map04151 | LJI308 | 131819916 | gdsc |
DNA replication | R-HSA-69306 | map03030 | LMP744 | 131819917 | gdsc |
Ras signaling pathway | R-HSA-168638 | map04014 | Lapatinib | 208908 | gdsc |
EGFR tyrosine kinase inhibitor resistance | R-ALL-1216523 | map01521 | Lapatinib | 208908 | gdsc |
DNA replication | R-HSA-69306 | map03030 | Leflunomide | 3899 | gdsc |
Protein stability and degradation | R-HSA-9837999 | 0 | Lenalidomide | 216326 | gdsc |
EGFR tyrosine kinase inhibitor resistance | R-ALL-1216523 | map01521 | Lestaurtinib | 126565 | gdsc |
Ras signaling pathway | R-HSA-168638 | map04014 | Linifanib | 11485656 | gdsc |
IGF1R signaling | R-HSA-2428924 | 0 | Linsitinib | 11640390 | gdsc |
Protein stability and degradation | R-HSA-9837999 | 0 | Luminespib | 135539077 | gdsc |
Cell cycle | R-HSA-1640170 | map04110 | MCT1_6447 | None | gdsc |
Protein stability and degradation | R-HSA-9837999 | 0 | MG-132 | 689043 | gdsc |
Apoptosis | R-HSA-109581 | map04210 | MIM1 | 131819918 | gdsc |
p53 signaling pathway | R-HSA-168638 | map04115 | MIRA-1 | 131819919 | gdsc |
Cell cycle | R-HSA-1640170 | map04110 | MK-1775 | 24856436 | gdsc |
PI3K-Akt signaling pathway | R-HSA-168638 | map04151 | MK-2206 | 131819920 | gdsc |
Cell cycle | R-HSA-1640170 | map04110 | MK-8776 | 131819921 | gdsc |
Protein stability and degradation | R-HSA-9837999 | 0 | ML323 | 131823391 | gdsc |
Wnt signaling pathway | R-HSA-195721 | map04310 | MN-64 | 131819922 | gdsc |
Mitosis | R-HSA-8854050 | 0 | MPS-1-IN-1 | None | gdsc |